Isosorbide-based Jelly Drug for Meniere's Disease
Using isosorbide as an ingredient, the agent helps improve labyrinthine hydrops associated with the disease.
11/0/705 Sanwa Kagaku Kenkyusho (SKK) has launched MENILET 70% Jelly, an oral osmotic diuretic indicated for the treatment of Meniere's disease, on July 11.
Using isosorbide as an ingredient, the agent helps improve labyrinthine hydrops associated with the disease.
The new chocolate-flavored jelly agent, which can be stored at room temperature, makes it easy to be carried anywhere, helping improve the patients' compliance.
It is estimated that there are presently about 60,000-70,000 patients with Meniere's disease in Japan.
All content and features on this website are copyrighted with all rights reserved. The full details can be found in our privacy statement
